Clinical characteristics, risk factors and outcome of severe Norovirus infection in kidney transplant patients: a case-control study

Table 3 Risk factors for Norovirus infection

Variable	Univariate analysis		Multivariate analysis
Variable	Odds ratio [IQR]	p (Wald’s test)	Odds ratio [IQR]	p (Wald’s test)
Diabetes	7.5 [1.7–32.8]	0.007	6.4 [1.2–35]	0.03
Induction therapy with ATG	2.5 [0.49–12.89]	0.273
Maintenance therapy with CT	1.8 [0.51–2.29]	0.847
Maintenance therapy with Tac	1.29 [0.64–2.59]	0.481
Maintenance therapy with CsA	0.5 [0.23–1.07]	0.045	0.34 [0.1–0.9]	0.03
CMV replication	1.3 [0.57–2.96]	0.533
Serum gammaglobulin level < 6.5 g/L	4.5 [0.97–20.8]	0.054	5.1 [0.96–26.5]	0.055
Lymphocyte count < 1000/mm³	2.14 [0.87–5.2]	0.096	3.8 [1.2–12]	0.02

Abbreviations: ATG Anti-Thymocyte Globulin, CsA Ciclosporin A, CT Corticosteroids, Tac Tacrolimus

ISSN: 1471-2334